Retension Pharmaceuticals
Mclean, US · Founded 2023 · Delaware corporation · 13 employees on LinkedIn
Retension Pharmaceuticals is a biopharmaceutical company developing treatments focused on optimizing blood pressure and cardiovascular health.
Founders & leadership
EK
Eric KellerExecutive
Board
MB
Michael BerendtBoard director
DO
Donald OldsBoard director
Funding
SEC filings, press & company announcements$22.4M disclosed across 2 of 3 rounds · 2023–2025
- Undisclosed amountSeries AAug 2024Source ↗
▶$12.3MraisedMay 2025 · 98 investors · PharmaceuticalsRule 506(b)
▶$12.3MraisedMay 2025 · 98 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Eric KellerExecutive Officer, Director
- Michael BerendtDirector
- Donald OldsDirector
- Offering amount
- $20M
- Amount sold
- $12.3M
- Sales commissions
- $701.4K
- Placement agents
- Collage Venture Partners, LLC, Stonehaven, LLC
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
▶$10.1MraisedMay 2024 · 132 investors · PharmaceuticalsRule 506(b)
▶$10.1MraisedMay 2024 · 132 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Donald OldsDirector
- Michael BerendtDirector
- Eric KellerExecutive Officer, Director
- Offering amount
- $11M
- Amount sold
- $10.1M
- Sales commissions
- $727.5K
- Placement agents
- Stonehaven, LLC, Collage Venture Partners, LLC
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware, 2023
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 3
by search overlap
Redica3 shared keywordsRedica offers an AI-enriched intelligence platform that unifies global regulatory, inspection, site, and post-market data to help companies manage risk and protect product quality. It serves quality, regulatory, and supply chain teams across industries including pharmaceutical, medtech, cosmetics, supplements, food, and financial services.
Reven Pharmaceuticals3 shared keywordsReven Pharmaceuticals develops pharmacological therapies aimed at treating the root causes of diseases by restoring immune system homeostasis. Its lead product, RJX, is a formulation designed to target immunologic function for inflammation-related conditions ranging from cancer to cardiovascular disease.
Adarepharmasolutions3 shared keywordsAdare Pharma Solutions is a contract development and manufacturing organization (CDMO) that develops and produces specialized oral-dose and injectable drug delivery systems at cGMP-compliant global manufacturing sites. It also provides in-house regulatory affairs support to help pharmaceutical clients bring products from molecule to market.
Companies competing with Retension Pharmaceuticals for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Retension Pharmaceuticals do?
- Retension Pharmaceuticals is a biopharmaceutical company developing treatments focused on optimizing blood pressure and cardiovascular health.
- How much funding has Retension Pharmaceuticals raised?
- Retension Pharmaceuticals has disclosed $22.4M raised across 2 of its 3 known rounds.
- Where is Retension Pharmaceuticals headquartered?
- Retension Pharmaceuticals is headquartered in Mclean, US.